Back to Search
Start Over
PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers.
- Source :
-
JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2019 Dec; Vol. 12 (12), pp. 2571-2573. Date of Electronic Publication: 2019 Aug 14. - Publication Year :
- 2019
- Subjects :
- Aged
Biomarkers blood
Carotid Arteries diagnostic imaging
Carotid Arteries metabolism
Carotid Artery Diseases blood
Carotid Artery Diseases diagnostic imaging
Cholesterol, LDL blood
Double-Blind Method
Dyslipidemias blood
Dyslipidemias diagnosis
Female
Fluorodeoxyglucose F18 administration & dosage
Humans
Inflammation Mediators blood
Male
Middle Aged
Netherlands
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals administration & dosage
Time Factors
Treatment Outcome
Anti-Inflammatory Agents therapeutic use
Antibodies, Monoclonal, Humanized therapeutic use
Anticholesteremic Agents therapeutic use
Carotid Arteries drug effects
Carotid Artery Diseases drug therapy
Dyslipidemias diagnostic imaging
PCSK9 Inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1876-7591
- Volume :
- 12
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- JACC. Cardiovascular imaging
- Publication Type :
- Report
- Accession number :
- 31422119
- Full Text :
- https://doi.org/10.1016/j.jcmg.2019.06.022